Humira generic availability, cost, and dosage
The Checkup by Singlecare
MARCH 8, 2024
It was FDA approved in August 2017 as a biosimilar, approved in 2021 as an interchangeable biosimilar, and became available in the United States in July of 2023. The warning states that because adalimumab products affect the immune system, there is an increased risk of serious infections that can lead to hospitalization or death.
Let's personalize your content